Skip to main content
OpenTrials

Clinical trial condition

Microvascular Inflammation

Explore clinical trials studying Microvascular Inflammation. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Microvascular Inflammation trial results

Recruiting

A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

NCT07219043

Conditions
Microvascular Inflammation
Locations
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Keck Hispital of University of Southern California (USC) Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Providence St. Joseph Hospital Orange Orange, California, United States
View all 44 locations
View Trial Details
Enrolling by invitation

A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE)

NCT07444489

Conditions
Antibody-mediated Rejection, Microvascular Inflammation
Locations
  • UCLA College of Medicine Los Angeles, California, United States
  • Cooperman Barnabas Medical Center West Orange, New Jersey, United States
  • California Pacific Medical Center (Sutter Health) San Francisco, California, United States
  • University of Nebraska Medical Center (UNMC) - Nebraska Medicine - Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details

Related conditions